Dr James Reihill
@drjamesreihill
Senior Reseach Fellow, School of Pharmacy, Queen's University Belfast
Research Focus: Exploring Ion Channel Modulation for Chronic Airway Disease Therapies.
ID: 1107277023909679104
17-03-2019 13:46:29
27 Tweet
79 Takipçi
225 Takip Edilen
Check out our video which explains a bit more about our collaborative cross-border BREATH Plus project focussed on building research capacity in #COPD, a disease of global burden and regional significance. SEUPB Interreg Tweets Wellcome-Wolfson Institute Experimental Medicine QUB Pharmacy School vimeo.com/378514610
Impact of BREATH Plus schools’ enagement to increase awareness of #COPD is best reflected in the letters from the children themselves. Below are examples from Belmont Primary, Stranraer (Dumfries & Galloway). Interreg Tweets UWS SEUPB breath-copd.org/feedback-lette…
Great to see our first paper of 2020 published online ahead of print in Journal of CF. The paper, first author Dr James Reihill, reports a link between increased levels of airway trypsin-like protease activity and survival in cystic fibrosis doi.org/10.1016/j.jcf.…
Here's a video from us, the respiratory team Belfast Trust, please RT this really important message. #StayAtHome #COVID19
Our latest published review - Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis. Genes MDPI #cysticfibrosis mdpi.com/2073-4425/12/3…
Following the BREATH-Almac Discovery partnership launch, Almac Group is delighted to announce the appointment of Dr James Reihill who will be joining the team to further support the exploration of drug development for major respiratory diseases. Read more: hubs.li/H0Sz_2X0
Almac Group is pleased to welcome Dr James Reihill to the Almac Discovery team as part of the organisations advancement of research in major respiratory diseases following the launch of the BREATH-collaboration. Read more on this: hubs.li/H0SMDq50
Delighted to see our collaborative work with GSK & Boston Pharmaceuticals published in Cell Chemical Biology. Special shout out & congratulations to Lisa Douglas & Dr James Reihill for all their effort & dedication. Queen's University Belfast 🎓 Click link for free access to pdf for 50 days authors.elsevier.com/a/1ee5U8jWWJpj…
My close colleague, Respiratory Consultant Prof Lorcan McGarvey tragically lost his 18 year old son in Jan. Fionntan's organs gave others the gift of life. Please see the JustGiving page in support of 'We are Donors' and donate if you can. Thank you! justgiving.com/fundraising/Fi…
Delighted to publish in Frontiers - Chemistry with Timothy Ferguson reporting a novel class of activity-based probes for #protease research. Frontiers | Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases | Chemistry. frontiersin.org/articles/10.33…
Congrats, Tuleen Alkawadri for winning the PhysRep #Europhysiology2022 abstract award for your work: Modulation of cholinergic contractions of murine #bronchial rings by b1-adrenoreceptor activation in #Respiratory Physiology! @SergeantGerard The Physiological Society Scandinavian Physiological Society #DPG #FEPS
Delighted to have had three presentations from my lab at the #FEBS Adv. Workshop on Proteolysis in Health & Disease, Bled Slovenia. Lisa Douglas Dr James Reihill and myself. QUB Pharmacy School #LovePostdocs Postdoctoral Development Centre at Queen's QUB Pharmacy School
We have awarded $220,000 in funding to Lorraine Martin, PhD, of Queen's University Belfast 🎓 to support development of a novel regenerative gene therapy platform technology. Read our press release to learn more >> emilysentourage.org/emilys-entoura… #research #cysticfibrosis #genetherapy #researchgrant
Enjoyed a fantastic day at the QUB Postdoc Showcase Postdoctoral Development Centre at Queen's themed "creating impact through collaboration". Delighted to win the QUB MHLS Faculty Research Prize for work done during my Innovate UK scholarship, with secondment to Almac Discovery and support from Cystic Fibrosis Trust.
Exciting work from Dr James Reihill QUB Pharmacy School discussing deubiquitinases as novel therapeutic targets to modulate ion channel function in CF. #UKCFC Cystic Fibrosis Trust UK Research and Innovation